Diabinese is one of 2 small molecule programs targeting Neurohypophyseal Diabetes Insipidus. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
FDA Application
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
2 competitors in Neurohypophyseal Diabetes Insipidus
Pitocin
Diabinese
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Regulatory
Jan 1, 1982
DIABINESE
NDA NDA011641
Sources
Details